TREATMENT

Advertisement
Nov 06 2025HEALTH

Mixing Brain Boosts: Can Teaming Up Treatments Help Memory?

Memory troubles can be tough, and scientists are always looking for ways to help. One tool they’re testing is called repetitive transcranial magnetic stimulation, or rTMS for short. But here’s the cool part: they’re not stopping there. They’re mixing rTMS with other treatments like electric brain za

reading time less than a minute
Nov 06 2025HEALTH

How an Online Course Changed Minds About Osteoarthritis

People with hip and knee osteoarthritis often have wrong ideas about their condition. They think surgery is the only way out. But doctors say exercise and weight loss should come first. A recent study looked at how an online course changed these beliefs. The course lasted four weeks. People could d

reading time less than a minute
Nov 05 2025HEALTH

AI Helps Couple Start a Family After 20 Years

A couple who had been trying to have a baby for 20 years finally succeeded with the help of a new AI technology. The man had a very low sperm count, making it hard to find healthy sperm for fertilization. But now, a new method called STAR uses AI to scan semen samples and find viable sperm. The STA

reading time less than a minute
Nov 04 2025HEALTH

Big Pharma Makes a Deal: Cheaper Drugs for Medicare

Two major drug companies, Lilly and Novo Nordisk, are close to striking a deal with the White House. They want to offer their weight loss drugs at a lower price. This is big news because it could mean more people can afford these medicines. The plan is to sell the lowest dose of their obesity drugs

reading time less than a minute
Nov 04 2025HEALTH

A Simple Fix for a Growing Problem: Why Can't We Get Levodopa to Those Who Need It?

Parkinson's disease is becoming more common. In the last 25 years, the number of people with this condition has doubled. Experts predict it will double again soon. Yet, the main treatment for Parkinson's, a drug called levodopa, is hard to find in many places. This drug is cheap, effective, and can

reading time less than a minute
Nov 03 2025HEALTH

Understanding Vulvar Extramammary Paget's Disease: A Closer Look at Recurrences

Vulvar Extramammary Paget's disease is a rare skin cancer. It often comes back after treatment. This makes it a tricky condition to manage. Doctors usually treat it by cutting out the affected area. But because it's so rare, there's still a lot we don't know. Like what makes it come back and how to

reading time less than a minute
Nov 02 2025HEALTH

Breaking Barriers: A New Hope for Lung Cancer Treatment

Lung cancer is a tough opponent, especially when it's the non-small-cell kind (NSCLC). Doctors usually don't recommend a common treatment called EGFR-TKIs for a specific mutation called EGFR exon 20 insertion. Why? Because these mutations don't respond well to the treatment. But here's a twist: a sp

reading time less than a minute
Nov 02 2025HEALTH

Colorado Springs Gets a Boost in Mental Health Care with New Treatment Option

Mental health care in Colorado Springs just got a significant upgrade. Serenity Mental Health Centers has introduced a new, faster treatment for Major Depressive Disorder (MDD). This treatment, called accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™), is cleared by the FDA. It's a big d

reading time less than a minute
Nov 01 2025HEALTH

A Rare Lung Infection: When Common Bacteria Take a Dangerous Turn

In the world of germs, some are more famous for causing trouble than others. One such troublemaker is Streptococcus pyogenes, better known as Group A Strep. It's usually known for causing sore throats and skin infections. But in rare cases, it can cause serious lung infections. A 52-year-old woman

reading time less than a minute
Nov 01 2025SCIENCE

How a Common Drug Might Help Fight a Brain Disease

People with a brain disease called multiple sclerosis (MS) often take a medicine named dimethyl fumarate (DMF). This drug helps to ease the symptoms of MS. But how exactly does it work? Scientists wanted to find out. They did some tests on mice to see what happens. First, they gave the mice a subst

reading time less than a minute